Regulate the Price of All Drugs Act

This bill creates a 13-member Prescription Drug Price Regulatory Commission that would recommend a "fair price" each year for every approved prescription drug, including insulin and vaccines, starting in 2027. The Secretary of Health and Human Services would set and publish these prices, and could revise them or allow temporary waivers. Manufacturers that charge more than the fair price would face civil penalties of 10 times the overcharge, and selling above the fair price would be enforced by the Federal Trade Commission, states, and private lawsuits. The bill also lets the government claim licenses to drug patents when owners sell above the fair price or do not supply enough, and lets the President use the Defense Production Act to increase domestic drug supply.

Full text and official record on Congress.gov

Sponsors

• Brad Sherman Democrat sponsor
• 0 cosponsors